Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reprogramming Lesional Macrophage Homeostasis via Interferon Regulatory Factor 5 Targeted siRNA Nanoimmunotherapy for Atherosclerosis.

ACS nano·2026
Same author

<i>IRF5</i> siRNA Nanoimmunotherapy: Restoring Macrophage Efferocytosis in Atherosclerosis.

Circulation·2025
Same author

Therapeutic Hydrogels: Properties and Biomedical Applications.

Chemical reviews·2025
Same author

Systemic reprogramming of tumour immunity via IL-10-mRNA nanoparticles.

Nature nanotechnology·2025
Same author

Adding Intranasal to Oral Administration of an Ultra-Rapid Near-Universal Drug Regimen Accelerates Relapse-Free Cure of Tuberculosis in Mice.

The Journal of infectious diseases·2025
Same author

Macrophage hitchhiking nanomedicine for enhanced β-elemene delivery and tumor therapy.

Science advances·2025

Related Experiment Video

Updated: Jan 4, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
09:11

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

10.2K

Magnetically Stimulated Drug Release Using Nanoparticles Capped by Self-Assembling Peptides.

Liping Ruan1, Wei Chen, Ruining Wang

  • 1School of Chemical Engineering , Sichuan University , Chengdu 610065 , China.

ACS Applied Materials & Interfaces
|October 30, 2019
PubMed
Summary
This summary is machine-generated.

This study introduces a novel peptide-functionalized nanoparticle drug carrier. It releases medication effectively using localized heating, showing high efficacy against pancreatic cancer cells.

Keywords:
alternating magnetic fieldchemotherapydrug deliverymagnetic heatingmesoporous silica nanoparticlesself-assembling peptidesthermoresponsive gatekeeper

More Related Videos

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

17.6K
Magnetic and Thermal-sensitive PolyN-isopropylacrylamide-based Microgels for Magnetically Triggered Controlled Release
08:39

Magnetic and Thermal-sensitive PolyN-isopropylacrylamide-based Microgels for Magnetically Triggered Controlled Release

Published on: July 4, 2017

9.4K

Related Experiment Videos

Last Updated: Jan 4, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
09:11

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

10.2K
Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

17.6K
Magnetic and Thermal-sensitive PolyN-isopropylacrylamide-based Microgels for Magnetically Triggered Controlled Release
08:39

Magnetic and Thermal-sensitive PolyN-isopropylacrylamide-based Microgels for Magnetically Triggered Controlled Release

Published on: July 4, 2017

9.4K

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Drug Delivery Systems

Background:

  • Developing targeted drug delivery systems is crucial for effective cancer therapy.
  • Mesoporous silica nanoparticles offer a versatile platform for drug encapsulation and controlled release.
  • Stimuli-responsive materials are needed to trigger drug release specifically at the tumor site.

Purpose of the Study:

  • To develop a self-assembling peptide-functionalized core-shell mesoporous silica nanoparticle for targeted drug delivery.
  • To investigate the controlled release of therapeutic agents using localized heating triggered by an alternating magnetic field.
  • To evaluate the in vitro cytotoxicity of the developed drug delivery system on pancreatic cancer cells.

Main Methods:

  • Fabrication of core-shell nanoparticles with a superparamagnetic iron oxide core and mesoporous silica shell.
  • Covalent conjugation of a self-assembling peptide (Boc-Phe-Phe-Gly-Gly-COOH) to the silica surface.
  • Utilizing peptide self-assembly/disassembly for pore blocking and cargo release at elevated local temperatures.
  • Drug release studies using fluorescein and daunorubicin, triggered by conventional and alternating magnetic field heating.
  • In vitro cytotoxicity assays on PANC-1 pancreatic carcinoma cells.

Main Results:

  • Successful synthesis and characterization of peptide-functionalized core-shell mesoporous silica nanoparticles.
  • Demonstrated temperature-triggered, localized drug release (fluorescein, daunorubicin) without bulk heating.
  • Alternating magnetic field heating effectively activated the drug delivery system.
  • Significant in vitro cytotoxicity observed against PANC-1 cells upon activation of the drug-loaded nanoparticles.
  • Control nanoparticles without drugs exhibited no significant cytotoxicity.

Conclusions:

  • The developed peptide-functionalized nanoparticle system enables precise, localized drug release for cancer therapy.
  • Alternating magnetic field-induced hyperthermia offers a non-invasive method for activating drug delivery.
  • This novel system shows promising potential for targeted treatment of pancreatic cancer with reduced side effects.